Back to search
Rheumatoid Arthritis (RA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rheumatoid Arthritis (RA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rheumatoid Arthritis (RA) trials you may qualify forThe primary goal of this cross-sectional study is to assess risk factors/predictors for dysphagia severity in RA. The secondary goals include demonstrating whe…
The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis
A Phase 1 study of HBI0101 BCMA-CART in B-Cell Mediated Autoimmune Rheumatic Diseases. The goal of the study is evaluation of safety and identification of the m…
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.
The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants with rheumatoi…
The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheuma…
This is a Phase 1, open-label, first-in-human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of KT502 administered subcuta…
Rheumatoid arthritis (RA) is the most common inflammatory arthritis, affecting around 1% of the UK population. It affects around 400,000 adults and is character…